Read this article:
Cellectis Announces Withdrawal of Follow-On Offering
Read this article:
Cellectis Announces Withdrawal of Follow-On Offering
The rest is here:
Tarsus Pharmaceuticals, Inc. Appoints Wendy Yarno to Board of Directors
See the rest here:
Mesoblast Corporate Update and Financial Results Webcast
Read the original here:
Novartis secures exclusive rights for potential acute respiratory distress syndrome cell therapy
View original post here:
Spring Bank Pharmaceuticals Stockholders Approve Combination with F-star Therapeutics
500 mg/dL)]]>
Read the rest here:
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China
Here is the original post:
Kiadis issues options to newly hired employees to meet its existing obligations
Read this article:
Burning Rock Reports Third Quarter 2020 Financial Results
See the rest here:
Resverlogix Files Notice of Annual and Special Meeting of Shareholders